ArticlePloS one2014

A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.

Eoghan de Barra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.